Metacognitive Therapy Compared to Cognitive-behavioral Therapy
Key facts
- Who runs it
- Karolinska Institutet
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 28 Jan 2026
- Expected to end
- Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Transdiagnostic metacognitive therapy
- Disorder-specific cognitive-behavioral therapy
- Record updated
- 18 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age 18 years or older,
- A principal diagnosis of generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder,
- No change in dose during the last six weeks if on pharmacological treatment, and
- Ability to read and speak Swedish
Who cannot take part
- Concurrent psychological treatment
- A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder,
- Acute suicide risk, or
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.
The 2 groups in the trial
- Transdiagnostic metacognitive therapyTreatment being tested
Metacognitive therapy in a transdiagnostic format; a single treatment protocol is used for all three anxiety disorders
- Disorder-specific cognitive-behavioral therapyExisting treatment, for comparison
Cognitive-behavioral therapy in a disorder-specific format; each of the three anxiety disorders is treated using a separate treatment protocol
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Transdiagnostic Metacognitive Therapy Compared to Disorder-specific Cognitive-behavioral Therapy for Anxiety Disorders: a Qualitative Study
- Record updated
- 18 August 2026